| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3807752 | Medicine | 2009 | 4 Pages |
Abstract
Almost 1 million people in the UK require anticoagulation to inhibit fibrin clot formation, propagation and embolization in the heart or blood vessels. The commonly used drugs heparin and warfarin require monitoring of their anticoagulant effect; new drugs with improved safety profiles are being introduced.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Muriel S. Shannon,